Fig. 1 · Structure
Documents & Downloads
trans-Cevimeline hydrochloride
M1 Cholinergic Agonist
Trans-Cevimeline hydrochloride is a selective M1 cholinergic agonist, known for its potential in modulating cholinergic neurotransmission. This compound exhibits significant biological activity relevant to neurodegenerative conditions, particularly Alzheimer's disease. Researchers can utilize trans-Cevimeline hydrochloride to investigate its effects on cognitive function and cholinergic signaling pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 107220-29-1 |
| Applications | M1 Cholinergic Agonist |
| Formula | C10H18ClNOS |
| Molecular Weight | 235.77 |
| Synonyms | AF102A hydrochloride |
| SMILES | C[C@@H]1SC[C@@]2(CN3CCC2CC3)O1.[H]Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.